| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REVIEW ARTICLE |
1 From the Council for Responsible Nutrition, Washington, DC (JNH and AD); the University of Bern, Bern, Switzerland (AA); Tufts University, Boston, MA (JB); Oregon State University, Corvallis, OR (TB, BF, and MGT); the University of California, Davis, Davis, CA (IJ); Arizona State University, Mesa, AZ (CSJ); King's College, London, United Kingdom (FJK); BASF, Ludwigshafen, Germany (KK); the University of Southern California, Los Angeles, CA (LP); Louisiana State University, Baton Rouge, LA (SP); and Heinrich Heine University, Dusseldorf, Germany (HS).
A robust database shows that dietary supplements of vitamins E and C are safe for the general population. Because these nutrients supply antioxidant and other functions for homeostasis and protection against free radical damage, supplementation has been intensively studied. Because of perceived benefits, many persons consume quantities of vitamins E and C well above the recommended dietary allowances. As safety guidance, tolerable upper intake levels have been established by the Food and Nutrition Board, Institute of Medicine, at 1000 mg for vitamin E and 2000 mg for vitamin C in adults. Many clinical trials with these vitamins have involved subjects with various diseases, and no consistent pattern of adverse effects has occurred at any intake. Numerous studies of vitamin C supplementation have provided no pattern of evidence to support concerns about safety other than occasional gastrointestinal upset or mild diarrhea resulting from the osmotic effects of unabsorbed quantities of vitamin C. Evidence of bleeding effects and other potential adverse effects of high vitamin E intakes in humans is not convincing. Evidence of adverse effects of vitamin C that result from its effects on iron absorption and metabolism has not been confirmed in clinical trials. Thus, we conclude from clinical trial evidence that vitamin E supplements appear safe for most adults in amounts 
1600 IU (1073 mg RRR-
-tocopherol or the molar equivalent of its esters) and that vitamin C supplements of 2000 mg/d are safe for most adults.
Key Words: Vitamin E • -tocopherol • tocopherol • vitamin C • ascorbic acid • risk assessment • safety • clinical trials
This article has been cited by other articles:
|
|
 |
|
  C. Bukutu, C. Le, and S. Vohra Asthma: A Review of Complementary and Alternative Therapies Pediatr. Rev., August 1, 2008; 29(8): e44 - e49. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rohekar Daily vitamin C prevented development of complex regional pain syndrome in adults with wrist fractures Evid. Based Med., April 1, 2008; 13(2): 48 - 48. [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Gomez-Cabrera, E. Domenech, M. Romagnoli, A. Arduini, C. Borras, F. V Pallardo, J. Sastre, and J. Vina Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance Am. J. Clinical Nutrition, January 1, 2008; 87(1): 142 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Leonard, J. D. Joss, D. J. Mustacich, D. H. Blatt, Y. S. Lee, and M. G. Traber Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2257 - 2266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E Wright, K. A Lawson, S. J Weinstein, and D. Albanes Reply to H Hemila and ER Miller III Am. J. Clinical Nutrition, July 1, 2007; 86(1): 262 - 263. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Frank, A. Budek, T. Lundh, R. S. Parker, J. E. Swanson, C. F. Lourenco, B. Gago, J. Laranjinha, B. Vessby, and A. Kamal-Eldin Dietary flavonoids with a catechol structure increase {alpha}-tocopherol in rats and protect the vitamin from oxidation in vitro J. Lipid Res., December 1, 2006; 47(12): 2718 - 2725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E Wright, K. A Lawson, S. J Weinstein, P. Pietinen, P. R Taylor, J. Virtamo, and D. Albanes Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1200 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Waitzberg, R. S. Torrinhas, and T. M. Jacintho New Parenteral Lipid Emulsions for Clinical Use JPEN J Parenter Enteral Nutr, July 1, 2006; 30(4): 351 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Munteanu, M. Taddei, I. Tamburini, E. Bergamini, A. Azzi, and J.-M. Zingg Antagonistic Effects of Oxidized Low Density Lipoprotein and {alpha}-Tocopherol on CD36 Scavenger Receptor Expression in Monocytes: INVOLVEMENT OF PROTEIN KINASE B AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma} J. Biol. Chem., March 10, 2006; 281(10): 6489 - 6497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Kirsh, R. B. Hayes, S. T. Mayne, N. Chatterjee, A. F. Subar, L. B. Dixon, D. Albanes, G. L. Andriole, D. A. Urban, and U. Peters Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst, February 15, 2006; 98(4): 245 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N Hathcock, A. Azzi, J. Blumberg, A. Dickinson, B. Frei, M. G Traber, C. S Johnston, K. Kraemer, S. Parthasarathy, and L. Packer Reply to H Hemila Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1142 - 1143. [Full Text] [PDF]
|
|
|
|
|
|
H. Hemila Potential harm of vitamin E supplementation Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1141 - 1142. [Full Text] [PDF]
|
|
|
|
|
|
L. Massey Safety of vitamin C Am. J. Clinical Nutrition, August 1, 2005; 82(2): 488 - 488. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
